New cancer drugs are making headlines, Iressa, Velcade, Avastin
New cancer drugs are making headlines, Iressa, Velcade, Avastin.
They each have an important new mechanism of action.
Iressa (gefitinib) is a new ORAL drug for lung cancer. It's an "epidermal growth factor inhibitor"...just for patients whose cancer progresses despite standard chemotherapy.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote